Gene · 22
Papers2,216
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,216
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quiescent Cells Actively Replenish CENP-A Nucleosomes to Maintain Centromere Identity and Proliferative Potential. | Dev Cell | 2019 | 31422918 | PubTator, text mining | PubMed |
| Psychophysical stress and strain of maritime pilots in Germany. A cross-sectional study. | PLoS One | 2019 | 31415636 | PubTator, text mining | PubMed |
| A PCBP1-BolA2 chaperone complex delivers iron for cytosolic [2Fe-2S] cluster assembly. | Nat Chem Biol | 2019 | 31406370 | PubTator, text mining | PubMed |
| Linking Cancer Metabolic Dysfunction and Genetic Instability through the Lens of Iron Metabolism. | Cancers (Basel) | 2019 | 31366108 | PubTator, text mining | PubMed |
| Sef1-Regulated Iron Regulon Responds to Mitochondria-Dependent Iron-Sulfur Cluster Biosynthesis in Candida albicans. | Front Microbiol | 2019 | 31354649 | PubTator, text mining | PubMed |
| MC4R and ENPP1 gene polymorphisms and their implication in maternal and neonatal risk for obesity. | Sci Rep | 2019 | 31350533 | PubTator, text mining | PubMed |
| Stabilizing heterochromatin by DGCR8 alleviates senescence and osteoarthritis. | Nat Commun | 2019 | 31350386 | PubTator, text mining | PubMed |
| Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial. | EBioMedicine | 2019 | 31326433 | PubTator, text mining | PubMed |
| Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. | Nutrients | 2019 | 31319590 | PubTator, text mining | PubMed |
| Prevalence of viral and non-viral hepatitis in Menoua Division, West Region, Cameroon: a retrospective hospital-based study. | Pan Afr Med J | 2019 | 31312324 | PubTator, text mining | PubMed |
| Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients. | PLoS One | 2019 | 31306461 | PubTator, text mining | PubMed |
| A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome. | Sci Transl Med | 2019 | 31292266 | PubTator, text mining | PubMed |
| The effect of gastrectomy on regorafenib exposure and progression-free survival in patients with advanced gastrointestinal stromal tumours. | Br J Clin Pharmacol | 2019 | 31290566 | PubTator, text mining | PubMed |
| Serum biomarkers of delirium in the elderly: a narrative review. | Ann Intensive Care | 2019 | 31263968 | PubTator, text mining | PubMed |
| Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients. | PLoS One | 2019 | 31260495 | PubTator, text mining | PubMed |
| The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathy. | Ther Adv Gastroenterol | 2019 | 31258622 | PubTator, text mining | PubMed |
| New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction. | J Clin Med | 2019 | 31252588 | PubTator, text mining | PubMed |
| CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | Cell Death Discov | 2019 | 31240132 | PubTator, text mining | PubMed |
| Decreased sEng plasma levels in hypertensive patients with endothelial dysfunction under chronic treatment with Perindopril. | Drug Des Devel Ther | 2019 | 31239642 | PubTator, text mining | PubMed |
| Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study. | Diabetes Metab Syndr Obes | 2019 | 31213867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22/papers?page=54